From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease.
Chierrito TPC, Pedersoli-Mantoani S, Roca C, Requena C, Sebastian-Perez V, Castillo WO, Moreira NCS, Pérez C, Sakamoto-Hojo ET, Takahashi CS, Jiménez-Barbero J, Cañada FJ, Campillo NE, Martinez A, Carvalho I.
Chierrito TPC, et al. Among authors: carvalho i.
Eur J Med Chem. 2017 Oct 20;139:773-791. doi: 10.1016/j.ejmech.2017.08.051. Epub 2017 Aug 26.
Eur J Med Chem. 2017.
PMID: 28863358